How to lose tumor suppression

David Philip Lane^{1

2}

Affiliations

¹ Karolinska Institutet, Biomedicum Quarter 7B-C Solnavägen 9, 17165 Solna, Sweden. dplane@p53lab.a-star.edu.sg.
² A*STAR, p53Lab, 8A Biomedical Grove, #06-06, Immunos, Singapore 138648.

Comment

David Philip Lane. Science. 2019.

. 2019 Aug 9;365(6453):539-540.

doi: 10.1126/science.aay4319.

David Philip Lane^{1

2}

¹ Karolinska Institutet, Biomedicum Quarter 7B-C Solnavägen 9, 17165 Solna, Sweden. dplane@p53lab.a-star.edu.sg.
² A*STAR, p53Lab, 8A Biomedical Grove, #06-06, Immunos, Singapore 138648.

No abstract available

Comment on

A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies.
Boettcher S, Miller PG, Sharma R, McConkey M, Leventhal M, Krivtsov AV, Giacomelli AO, Wong W, Kim J, Chao S, Kurppa KJ, Yang X, Milenkowic K, Piccioni F, Root DE, Rücker FG, Flamand Y, Neuberg D, Lindsley RC, Jänne PA, Hahn WC, Jacks T, Döhner H, Armstrong SA, Ebert BL. Boettcher S, et al. Science. 2019 Aug 9;365(6453):599-604. doi: 10.1126/science.aax3649. Science. 2019. PMID: 31395785 Free PMC article.